Chlamydia antigens and corresponding DNA fragments and uses thereof
AssigneeAventis Pasteur Limited
InventorsAndrew D. Murdin, Raymond P. Oomen, Pamela L. Dunn
Life of this patent
Estimating the term…
Abstract
In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding a lorf2 protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the lorf2 gene in the host. Modifications are possible within the scope of this invention.
Claims10
An isolated polynucleotide comprising a polynucleotide from a strain of Chlamydia, selected from the group consisting of:
- (a) a polynucleotide comprising the nucleotide sequence of SEQ ID NO:
- 1;
- and
- (b) a polynucleotide which hybridizes under stringent hybridizing conditions of 6×SSC containing 50% formamide at 42° C. with a polynucleotide that has a complementary sequence to the full length of:
- SEQ ID NO:
- 1, the coding sequence of SEQ ID NO:
- 1, or the open reading frame(s) of SEQ ID NO:
- 1;
- wherein said isolated polynucleotide, when administered in an immunogenically-effective amount to a mammal, induces an immune response by said mammal against Chlamydia.
Dependencies are inferred from the claim text.